Anticoagulant fusion proteins and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11897924
APP PUB NO 20210070817A1
SERIAL NO

16982966

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is a fusion protein including an Ixodes ricinus salivary gland polypeptide. In particular, it relates to a fusion protein including at least one Ixodes ricinus salivary gland polypeptide, at least one serum albumin polypeptide and at least one linker peptide. Also disclosed is the use of such a fusion protein for preventing or treating thrombus formation and/or thrombus growth, as well as pharmaceutical compositions, medicaments and methods including such a fusion protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOXODES SA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Demoulin, Stéphanie Antheit, BE 4 1
Godfroid, Edmond Brussels, BE 15 29
Guyaux, Michel Woluwe-Saint-Pierre, BE 6 12
Tassignon, Joël Roux, BE 4 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 13, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 13, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 13, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00